[1]杨菊红 阿皮也提?牙生那洪 热依汉古丽?艾比布拉 阿布来提?艾白都拉石珍珍张立弋 帕提古丽?买买提明 依巴代提?麦提图尔荪 阿不力米提?艾力热则耶?艾科拜尔 阿布都米吉提?阿布都热西提.血清α-L-岩藻糖苷酶水平与新疆和田地区住院2型糖尿病患者脂代谢的关系[J].国际内分泌代谢杂志,2019,39(05):289-293.[doi:10.3760/cma.j.issn.1673-4157.2019.05.001]
　Yang Juhong,Apiyeti Yashengnahong,Reyehanguli Abibra,et al.Relationship between serum alpha-L-fucosidase level and lipid metabolism in hospitalized patients with type 2 diabetes mellitus in Hetian area of Xinjiang[J].International Journal of Endocrinology and Metabolism,2019,39(05):289-293.[doi:10.3760/cma.j.issn.1673-4157.2019.05.001]
点击复制

血清α-L-岩藻糖苷酶水平与新疆和田地区住院2型糖尿病患者脂代谢的关系()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
39
期数:
2019年05期
页码:
289-293
栏目:
论著
出版日期:
2019-09-20

文章信息/Info

Title:
Relationship between serum alpha-L-fucosidase level and lipid metabolism in hospitalized patients with type 2 diabetes mellitus in Hetian area of Xinjiang
作者:
杨菊红1; 2 阿皮也提?牙生那洪2 热依汉古丽?艾比布拉2 阿布来提?艾白都拉2石珍珍1张立弋1 帕提古丽?买买提明2 依巴代提?麦提图尔荪2 阿不力米提?艾力2热则耶?艾科拜尔2 阿布都米吉提?阿布都热西提2
1天津医科大学朱宪彝纪念医院肾内科,国家卫生健康委员会激素与发育重点实验室(天津医科大学),天津市代谢性疾病重点实验室,天津医科大学朱宪彝纪念医院&天津市内分泌研究所 300134; 2新疆和田地区人民医院西院区内一科 848000
Author(s):
Yang Juhong1; 2;  Apiyeti Yashengnahong2;  Reyehanguli Abibra2;  Ablai Abdullah2;  Shi Zhenzhen1;  Zhang Liyi1;  Patriculi Maimaiti2;  Ibadeti Matilthurson2;  Abelimi Ali2;  Rezeye Aikebaier2;  Abdumijiti Abdurexiti2
1Department of Nephropathy, NHC Key Laboratory of Hormones and Development(Tianjin Medical University), Tianjin Key Laboratory of Metabolic Diseases, Tianjin Medical University Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin 300134, China; 2Department of Internal Medicine, West Hospital, The People’s Hospital of Hetian District in Xinjiang, Hetian 848000, China
关键词:
2型糖尿病;  α-L-岩藻糖苷酶;  糖代谢;  脂代谢
Keywords:
Type 2 diabetes mellitus;  Alpha-L-fucosidase;  Glucose metabolism;  Lipid metabolism
DOI:
10.3760/cma.j.issn.1673-4157.2019.05.001
摘要:
目的 研究新疆和田地区2型糖尿病患者的脂代谢特点及其与血清α-L-岩藻糖苷酶(AFU)水平的关系。方法 纳入2018年1-12月在新疆和田地区人民医院内一科住院的2型糖尿病患者1 000例,其中男性456例,女性544例,平均年龄(54.9±11.3)岁。回顾性分析患者血脂代谢特点及其与血清AFU的关系,并分析维吾尔族与汉族患者的差异。结果 本组人群平均糖化血红蛋白为(9.4±2.3)%,15.8%的患者达到中华医学会糖尿病学分会推荐的控制目标; 低密度脂蛋白-胆固醇的达标率为53.5%,总胆固醇、甘油三酯及高密度脂蛋白-胆固醇(HDL-C)的达标率均在30%左右,两个民族间差异无统计学意义。多元logistic回归模型分析发现,血清总蛋白(OR=1.038,95% CI:1.015～1.062,P=0.001)、空腹静脉血糖(OR=1.051,95% CI:1.023～1.079,P<0.001)、载脂蛋白A1(OR=7.830,95% CI:2.831～21.654,P<0.001)与AFU呈正相关,HDL-C与AFU呈负相关(OR=0.312,95% CI:0.142～0.684,P=0.004)。维吾尔族患者AFU水平低于汉族患者,且该作用独立于其他影响因素(OR=6.185,95% CI:3.087～12.392,P<0.001)。结论 新疆维吾尔族2型糖尿病患者血糖及血脂达标率均不高。AFU与2型糖尿病患者的糖、脂代谢均密切相关,AFU升高是2型糖尿病患者HDL-C下降的危险因素。
Abstract:
Objective To study the characteristics of lipid metabolism and its relationship with serum alpha-L-fucosidase(AFU)level in patients with type 2 diabetes mellitus in Hetian, Xinjiang.Methods A total of 1 000 patients with type 2 diabetes were enrolled in the Department of Internal Medicine, The People’s Hospital of Hetian District in Xinjiang from January to December in 2018, including 456 males and 544 females, with an average age of(54.9±11.3)years. The characteristics of blood lipid metabolism and its relationship with serum AFU were retrospectively analyzed, and the differences between Uygur and Han patients were analyzed.Results The average glycosylated hemoglobin A1c of this group was(9.4±2.3)%, with only 15.8% patients met the target recommended by Chinese Diabetes Society. Only 53.5%patients achieved the goal of control in low density lipoprotein-cholesterol, and about 30% patients achieved the goal of control in total cholesterol, triglyceride and high density lipoprotein-cholesterol(HDL-C). There was no statistical difference between Uygur and Han ethnics. Multiple logistic regression analysis showed that serum total protein(OR=1.038, 95% CI: 1.015-1.062, P=0.001), fasting plasma blood glucose(OR=1.051, 95% CI: 1.023-1.079, P<0.001), apolipoprotein A1(OR=7.830, 95% CI: 2.831-21.654, P<0.001)were positively correlated with AFU, and HDL-C was negatively correlated with AFU(OR=0.312, 95% CI: 0.142-0.684, P=0.004). The level of AFU in Uygur patients was lower than that in Han patients, and the effect was independent of other influencing factors(OR=6.185, 95% CI: 3.087-12.392, P<0.001).Conclusions The percentages of patients obtaining blood glucose and lipid control are not high in type 2 diabetes in Uygur ethnic group in Xinjiang. AFU is closely related to glucose and lipid metabolism in type 2 diabetic patients. Elevated AFU is a risk factor for the decrease of HDL-C in type 2 diabetic patients.

参考文献/References:

[1] 尼瓦尔·阿不里孜,王磊,马依彤,等.新疆和田维吾尔族居民糖尿病患病率调查[J]. 中华全科医学,2011,9(8):1275-1277.
[2] 鲜木斯娅·肉孜,啥丽达·木沙,阿依努尔·木合它尔. 新疆和田地区维吾尔族和汉族人群糖脂代谢的流行病学调查分析[J].新疆医科大学学报,2009,32(7):880-884. DOI:10.3969/j.issn.1009-5551.2009.07.017.
[3] 中华医学会糖尿病学分会.中国2型糖尿病患者防治指南[J].中华糖尿病杂志,2018,10(1):4-67.DOI:10.3760/cma.j.issn.1674-5809.2018.01.003.
[4] 李英,李玲玲,王敏哲.维吾尔族、汉族2型糖尿病病人胰岛素抵抗与颈动脉内膜中层厚度的相关性分析[J].中西医结合心脑血管病杂志,2016,14(20):2415-2417. DOI:10.3969/j.issn.1672-1349.2016.20.026.
[5] Waidely E,Al-Youbi AO,Bashammakh AS,et al.Alpha-L-fucosidase immunoassay for early detection of hepatocellular carcinoma[J].Anal Chem,2017,89(17):9459-9466.DOI:10.1021/acs.analchem.7b02284.
[6] Conti F,Dall’Agata M,Gramenzi A,et al.Biomarkers for the early diagnosis of bacterial infection and the surveillance of hepatocellular carcinoma in cirrhosis[J].Biomark Med,2015,9(12):1343-1351. DOI:10.2217/bmm.15.100.
[7] Komosińska-Vassev K,Olczyk K,Koz’ma EM,et al. Alterations of glycosaminoglycan metabolism in the development of diabetic complications in relation to metabolic control[J].Clin Chem Lab Med,2005,43(9):924-929.DOI:10.1515/CCLM.2005.158.
[8] 董磊,刘娟,马红雨,等. 血清α-L-岩藻糖苷酶测定在2型糖尿病合并微血管损伤中的临床意义[J].中华临床医师杂志(电子版),2011,5(21):6446-6447.DOI:10.3877/cma.j.issn.1674-0785.2011.21.045.
[9] 陈峻,马涛,崔天盆.糖尿病肾病患者血清胱抑素C及AFU联合检测的临床意义[J]. 标记免疫分析与临床,2014,21(3):347-348. DOI:10.11748/bjmy.issn.1006-1703.2014.03.041.
[10] Suh MJ,Tovchigrechko A,Thovarai V,et al.Quantitative differences in the urinary proteome of siblings discordant for type 1 diabetes include lysosomal enzymes[J].J Proteome Res,2015,14(8):3123-3135.DOI:10.1021/acs.jproteome.5b00052.
[11] Maciejczyk M,Kossakowska A,Szulimowska J,et al.Lysosomal exoglycosidase profile and secretory function in the salivary glands of rats with streptozotocin-induced diabetes[J].J Diabetes Res,2017,2017:9850398.DOI:10.1155/2017/9850398.
[12] Zhang Y,Yang J,Zheng M,et al.Clinical characteristics and predictive factors of subclinical diabetic nephropathy[J].Exp Clin Endocrinol Diabetes,2015,123(2):132-138.DOI:10.1055/s-0034-1396810.
[13] Lu ZY,Cen C,Shao Z,et al.Association between serum α-L-fucosidase and non-alcoholic fatty liver disease: cross-sectional study[J].World J Gastroenterol,2016,22(5):1884-1890. DOI:10.3748/wjg.v22.i5.1884.
[14] Morita M,Ishida N,Uchiyama K,et al.Fatty liver induced by free radicals and lipid peroxidation[J].Free Radic Res,2012,46(6):758-765.DOI:10.3109/10715762.2012.677840.
[15] Bell LN,Molleston JP,Morton MJ,et al.Hepatic lipid peroxidation and cytochrome P-450 2E1 in pediatric nonalcoholic fatty liver disease and its subtypes[J].J Clin Gastroenterol,2011,45(9):800-807.DOI:10.1097/MCG.0b013e31821377e4.
[16] Hartnett ME,Stratton RD,Browne RW,et al.Serum markers of oxidative stress and severity of diabetic retinopathy[J].Diabetes Care,2000,23(2):234-240.DOI:10.2337/diacare.23.2.234.
[17] Lee YJ,Lee HR,Shim JY,et al.Relationship between white blood cell count and nonalcoholic fatty liver disease[J].Dig Liver Dis,2010,42(12):888-894.DOI:10.1016/j.dld.2010.04.005.
[18] Ali S,Jenkins Y,Kirkley M,et al.Leukocyte extravasation: an immunoregulatory role for alpha-L-fucosidase?[J].J Immunol,2008,181(4):2407-2413.DOI: 10.4049/jimmunol.181.4.2407.

相似文献/References:

[1]曾静波,王姮.2型糖尿病与自身免疫反应[J].国际内分泌代谢杂志,2007,(04):259.
[2]朱素君,谢锦桃,刘军,等.二甲双胍：2型糖尿病治疗的基础药[J].国际内分泌代谢杂志,2007,(04):280.
[3]刘艳清 易秋艳 邵加庆.肠道菌群与肥胖和糖尿病的关系[J].国际内分泌代谢杂志,2015,(01):31.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.007]
　Liu Yanqing,Yi Qiuyan,Shao Jiaqing..Relationship between gut microbiota, obesity and diabetes[J].International Journal of Endocrinology and Metabolism,2015,(05):31.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.007]
[4]姚旻 赵爱源 张宏.肠道菌群与2型糖尿病[J].国际内分泌代谢杂志,2015,(01):35.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.008]
　Yao Min*,Zhao Aiyuan,Zhang Hong..Relationship between gut microbiota and type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2015,(05):35.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.008]
[5]赵丽娟,徐宽枫,杨涛,等.SLC30A8和PTPRD基因多态性与南京地区中老年人群2型糖尿病的相关性研究[J].国际内分泌代谢杂志,2015,(03):145.[doi:10.3760/cma.j.issn.1673-4157.2015.03.001]
　Zhao Lijuan*,Xu Kuanfeng,Yang Tao,et al.Relationship between SLC30A8 and PTPRD gene polymorphisms and type 2 diabetes in middle aged and elderly people in Nanjing area[J].International Journal of Endocrinology and Metabolism,2015,(05):145.[doi:10.3760/cma.j.issn.1673-4157.2015.03.001]
[6]王洁,何媛,于珮.糖尿病肾病的相关危险因素分析[J].国际内分泌代谢杂志,2015,(03):153.[doi:10.3760/cma.j.issn.1673-4157.2015.03.003]
　Wang Jie*,He Yuan,Yu Pei..Risk factors of diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(05):153.[doi:10.3760/cma.j.issn.1673-4157.2015.03.003]
[7]刘帅,张萍,方毅,等.2型糖尿病合并无症状冠状动脉钙化的相关危险因素分析[J].国际内分泌代谢杂志,2015,(03):158.[doi:10.3760/cma.j.issn.1673-4157.2015.03.004]
　Liu Shuai*,Zhang Ping,Fang Yi,et al.Analysis of the risk factors related with asymptomatic coronary calcification for type 2 diabetic patients[J].International Journal of Endocrinology and Metabolism,2015,(05):158.[doi:10.3760/cma.j.issn.1673-4157.2015.03.004]
[8]徐庆海,马颖,李铁马.2型糖尿病患者高甘油三酯血症-腰围表型与甲状腺功能异常的关系[J].国际内分泌代谢杂志,2015,(04):222.[doi:10.3760/cma.j.issn.1673-4157.2015.04.002]
　Xu Qinghai,Ma Ying,Li Tiema..Association of hypertriglyceridaemic-waist phenotype with thyroid dysfunction in patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(05):222.[doi:10.3760/cma.j.issn.1673-4157.2015.04.002]
[9]潘道延,沈洁,朱筱,等.利格列汀对2型糖尿病大鼠代谢性内毒素血症的影响[J].国际内分泌代谢杂志,2015,(04):230.[doi:10.3760/cma.j.issn.1673-4157.2015.04.004]
　Pan Daoyan,Shen Jie,Zhu Xiao,et al.Effects of linagliptin on metabolic endotoxemia in type 2 diabetic rats[J].International Journal of Endocrinology and Metabolism,2015,(05):230.[doi:10.3760/cma.j.issn.1673-4157.2015.04.004]
[10]黄桥,白洁,杜洪泉.一种新的脂肪细胞因子——cartonectin[J].国际内分泌代谢杂志,2015,(04):265.[doi:10.3760/cma.j.issn.1673-4157.2015.04.014]
　Huang Qiao*,Bai Jie,Du Hongquan..A novel adipokine--cartonectin[J].International Journal of Endocrinology and Metabolism,2015,(05):265.[doi:10.3760/cma.j.issn.1673-4157.2015.04.014]

备注/Memo

备注/Memo:
通信作者:杨菊红,Email:megii0315@126.com
Corresponding author: Yang Juhong, Email:megii0315@126.com
更新日期/Last Update: 2019-09-20